Aspirin may help prevent serious liver disease including cancer, a new study has found. According to the results of this study, which was by the National Cancer Institute in Rockville, Md., aspirin users are 41 percent less likely to develop liver cancer and 45 percent less likely to die from chronic liver disease than non-users.
"These associations are prominent with the use of aspirin, and if confirmed, might open new vistas for chemoprevention of hepatocellular carcinoma and chronic liver disease," the study's author Vikrant Sahasrabuddhe wrote in the December 5 issue of the Journal of the National Cancer Institute.
More than 300,000 people aged 50 to 71 were followed for a period of up to 10 to 12 years for this study. During that time, more than 400 participants died from chronic liver disease and 250 were diagnosed with liver cancer.
The study also found that people who took non-aspirin nonsteroidal anti-inflammatory drugs were 26 percent less likely to die from chronic liver disease but no less likely to be diagnosed with liver cancer.
For comments and feedback contact: editorial@rttnews.com
Health News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.